Company report
Astellas Pharma Inc.
Healthcare & Life Sciences · Tokyo, Japan
Astellas Pharma Inc. currently has a Rotten Score of 7/100 and is classified as Mostly Decent. The score is based on 1 approved evidence record.
What has Astellas Pharma Inc. done?
Documented incidents behind the score, most recent first.
- Astellas U.S. subsidiary paid $100 million to settle Medicare copay-kickback allegationsJuly 1, 2013–December 31, 2014 · Fraud & Corruption · high severity
At a glance
- Industry
- Healthcare & Life Sciences
- Company size
- Unknown
- Headquarters
- Tokyo, Asia-Pacific, Japan
- Website
- www.astellas.com/en
Astellas Pharma Inc. is a major Japan-headquartered company operating in the healthcare & life sciences sector.
Assess documented harm
How serious is each kind of harm at this company? 1 = low · 5 = severe. 1 of 8 categories have verified evidence.
| Category | Evidence | Your rating · 1 low → 5 severe |
|---|---|---|
Fraud & Corruption 1 verified record | 1 | |
Corporate Misconduct No evidence yet | — | |
Human Rights & Exploitation No evidence yet | — | |
Deceptive Practices No evidence yet | — | |
Environmental Harm No evidence yet | — | |
Sustainability Deception No evidence yet | — | |
Workplace Misconduct No evidence yet | — | |
Financial Misconduct No evidence yet | — |
Ratings affect the Rotten Score, lightly. The average rating moves a category's contribution by up to 10%. Verified evidence drives the score, so categories with no evidence add nothing yet. How the score works